| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Resveratrol | Acute Lung Injury | 2 | PM | 38626830 | 📋 | Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation |
| Resveratrol | Acute Lung Injury | 5 | PM | 36091774 | 📋 | The therapeutic efficacy of resveratrol for acute lung injury-A meta-analysis of preclinical trials |
| Resveratrol | Acute Lung Injury | 4 | PM | 35652405 | 📋 | Resveratrol ameliorates LPS-induced acute lung injury mouse model via induction of Tristetraprolin |
| Resveratrol | Acute Lung Injury | 3 | PM | 34992821 | 📋 | Resveratrol inhibits cell apoptosis by suppressing long noncoding RNA (lncRNA) XLOC_014869 during lipopolysaccharide-induced acute lung injury in rats |
| Resveratrol | Acute Lung Injury | 6 | PM | 23921197 | 📋 | Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress |
| Resveratrol | Acute Lung Injury | 1 | PM | 21284090 | 📋 | Protective Effect of Resveratrol on Acute Lung Injury Induced by Lipopolysaccharide in Mice |
| Resveratrol | Acute Respiratory Distress Syndrome | 1 | PM | 33722710 | 📋 | Resveratrol-mediated Attenuation of Superantigen-driven Acute Respiratory Distress Syndrome is Mediated by Microbiota in the Lungs and Gut |
| Resveratrol | Allergic Asthma | 1 | PM | 35265071 | 📋 | The Ability of Resveratrol to Attenuate Ovalbumin-Mediated Allergic Asthma Is Associated With Changes in Microbiota Involving the Gut-Lung Axis, Enhanced Barrier Function and Decreased Inflammation in the Lungs |
| Resveratrol | Asthma | 3 | PM | 35950118 | 📋 | Resveratrol in the treatment of asthma based on an animal model |
| Resveratrol | Asthma | 2 | PM | 33379407 | 📋 | Effects of Resveratrol on Thymic Stromal Lymphopoietin Expression in Mast Cells |
| Resveratrol | Asthma | 1 | PM | 32963508 | 📋 | Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases |
| Resveratrol | Bronchopulmonary Dysplasia | 3 | PM | 38710061 | 📋 | Protective Effects of Resveratrol Against Airway Hyperreactivity, Oxidative Stress, and Lung Inflammation in a Rat Pup Model of Bronchopulmonary Dysplasia |
| Resveratrol | Bronchopulmonary Dysplasia | 1 | PM | 33215523 | 📋 | Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction |
| Resveratrol | Bronchopulmonary Dysplasia | 2 | PM | 26174235 | 📋 | Resveratrol Attenuates Hyperoxia-Induced Oxidative Stress, Inflammation and Fibrosis and Suppresses Wnt/β-catenin Signalling in Lungs of Neonatal Rats |
| Resveratrol | COPD | 7 | PM | 35556386 | 📋 | Resveratrol Reduces Arterial Stiffness and Improves Functional Capacity in Patients with COPD |
| Resveratrol | COPD | 6 | PM | 32963508 | 📋 | Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases |
| Resveratrol | COPD | 1 | PM | 27035424 | 📋 | Effects of Resveratrol and Genistein on Nuclear factor‑κB, Tumor Necrosis Factor‑α and Matrix metalloproteinase‑9 in Patients With Chronic Obstructive Pulmonary Disease |
| Resveratrol | COPD | 8 | PM | 24289075 | 📋 | Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation |
| Resveratrol | COPD | 4 | PM | 20801891 | 📋 | Resveratrol Impairs the Release of Steroid-Resistant Inflammatory Cytokines From Human Airway Smooth Muscle Cells in Chronic Obstructive Pulmonary Disease |
| Resveratrol | COPD | 5 | PM | 18598184 | 📋 | The Effects of Dietary Phenolic Compounds on Cytokine and Antioxidant Production by A549 Cells |
| Resveratrol | COPD | 2 | PM | 18507337 | 📋 | [Effect of Resveratrol on Chronic Obstructive Pulmonary Disease in Rats and Its Mechanism] |
| Resveratrol | COPD | 3 | PM | 14586044 | 📋 | Inhibition by Red Wine Extract, Resveratrol, of Cytokine Release by Alveolar Macrophages in COPD |
| Resveratrol | Cystic Fibrosis | 2 | PM | 32267731 | 📋 | Resveratrol Restores Intracellular Transport in Cystic Fibrosis Epithelial Cells |
| Resveratrol | Cystic Fibrosis | 3 | PM | 27081574 | 📋 | Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis |
| Resveratrol | Cystic Fibrosis | 1 | PM | 26092868 | 📋 | Resveratrol Increases F508del-CFTR Dependent Salivary Secretion in Cystic Fibrosis Mice |
| Resveratrol | Dry Mouth | 1 | PM | 36155056 | 📋 | Resveratrol alleviates salivary gland dysfunction induced by ovariectomy in rats |
| Resveratrol | High-Altitude Polycythemia | 1 | PM | 32468662 | 📋 | Quantitative Proteomics Reveals the Effects of Resveratrol on High-Altitude Polycythemia Treatment |
| Resveratrol | Hyperoxia | 5 | PM | 35381611 | 📋 | The mechanism of hyperoxia-induced neonatal renal injury and the possible protective effect of Resveratrol |
| Resveratrol | Hyperoxia | 4 | PM | 35240708 | 📋 | Resveratrol attenuates hyperoxia lung injury in neonatal rats by activating SIRT1/PGC-1α signaling pathway |
| Resveratrol | Hyperoxia | 3 | PM | 33215523 | 📋 | Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction |
| Resveratrol | Hyperoxia | 2 | PM | 32357375 | 📋 | Resveratrol Relieves Hyperoxia-Induced Brain Injury in Neonatal Rats by Activating Sirt1 |
| Resveratrol | Hyperoxia | 6 | PM | 28420272 | 📋 | Resveratrol suppresses hyperoxia-induced nucleocytoplasmic shuttling of SIRT1 and ROS production in PBMC from preterm infants in vitro |
| Resveratrol | Hyperoxia | 1 | PM | 26174235 | 📋 | Resveratrol Attenuates Hyperoxia-Induced Oxidative Stress, Inflammation and Fibrosis and Suppresses Wnt/β-catenin Signalling in Lungs of Neonatal Rats |
| Resveratrol | Hypobaric Hypoxia | 3 | PM | 37308410 | 📋 | [Resveratrol attenuates cardiac function impairment in plateau hypobaric hypoxia rats] |
| Resveratrol | Hypobaric Hypoxia | 2 | PM | 36903296 | 📋 | Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia |
| Resveratrol | Hypobaric Hypoxia | 1 | PM | 36080305 | 📋 | Resveratrol Ameliorates High Altitude Hypoxia-Induced Osteoporosis by Suppressing the ROS/HIF Signaling Pathway |
| Resveratrol | Hypoxia | 7 | PM | 35893296 | 📋 | Protective Effect of Resveratrol against Hypoxia-Induced Neural Oxidative Stress |
| Resveratrol | Hypoxia | 6 | PM | 35300418 | 📋 | Rapamycin and Resveratrol Modulate the Gliotic and Pro-Angiogenic Response in Müller Glial Cells Under Hypoxia |
| Resveratrol | Hypoxia | 1 | PM | 34934403 | 📋 | Hypoxia: Role of SIRT1 and the protective effect of resveratrol in ovarian function |
| Resveratrol | Hypoxia | 5 | PM | 33389500 | 📋 | Downregulated hypoxia-inducible factor 1α improves myoblast differentiation under hypoxic condition in mouse genioglossus |
| Resveratrol | Hypoxia | 4 | PM | 33106825 | 📋 | [Resveratrol inhibits hypoxia-induced oxidative stress and proliferation in pulmonary artery smooth muscle cells through the HIF-1α/NOX4/ROS signaling pathway] |
| Resveratrol | Hypoxia | 3 | PM | 32296107 | 📋 | Resveratrol Attenuates Hypoxia-Induced Neuronal Cell Death, Inflammation and Mitochondrial Oxidative Stress by Modulation of TRPM2 Channel |
| Resveratrol | Hypoxia | 2 | PM | 20349725 | 📋 | [Protective Effects of Resveratrol on Neonatal Rat Cardiomyocyte Lesion Induced by Hypoxia] |
| Resveratrol | Intermittent Hypoxia | 1 | PM | 31412263 | 📋 | Resveratrol Prevents Chronic Intermittent Hypoxia-Induced Cardiac Hypertrophy by Targeting the PI3K/AKT/mTOR Pathway |
| Resveratrol | Interstitial Lung Disease | 4 | PM | 38745204 | 📋 | Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway |
| Resveratrol | Interstitial Lung Disease | 3 | PM | 37089962 | 📋 | Potential of resveratrol in the treatment of interstitial lung disease |
| Resveratrol | Interstitial Lung Disease | 2 | PM | 36500562 | 📋 | Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway |
| Resveratrol | Interstitial Lung Disease | 1 | PM | 30930172 | 📋 | Systemic Treatment With Resveratrol Alleviates Adjuvant Arthritis-Interstitial Lung Disease in Rats via Modulation of JAK/STAT/RANKL Signaling Pathway |
| Resveratrol | Lung Cancer | 33 | PM | 37968995 | 📋 | Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2 |
| Resveratrol | Lung Cancer | 32 | PM | 37840424 | 📋 | Resveratrol augments paclitaxel sensitivity by modulating miR-671-5p/STOML2/PINK1/Parkin-mediated autophagy signaling in A549 cell |
| Resveratrol | Lung Cancer | 31 | PM | 37001272 | 📋 | Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma |
| Resveratrol | Lung Cancer | 30 | PM | 36866538 | 📋 | Destruction of the cellular antioxidant pool contributes to resveratrol-induced senescence and apoptosis in lung cancer |
| Resveratrol | Lung Cancer | 29 | PM | 36569479 | 📋 | Resveratrol regulates PINK1/Parkin-mediated mitophagy via the lncRNA ZFAS1-miR-150-5p-PINK1 axis, and enhances the antitumor activity of paclitaxel against non-small cell lung cancer |
| Resveratrol | Lung Cancer | 28 | PM | 36370924 | 📋 | Resveratrol Suppresses Lung Cancer by Targeting Cancer Stem-Like Cells and Regulating Tumor Microenvironment |
| Resveratrol | Lung Cancer | 27 | PM | 36339614 | 📋 | Resveratrol activates CD8+ T cells through IL-18 bystander activation in lung adenocarcinoma |
| Resveratrol | Lung Cancer | 26 | PM | 36142801 | 📋 | Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells |
| Resveratrol | Lung Cancer | 25 | PM | 35984029 | 📋 | Research progress in elucidating the mechanisms underlying resveratrol action on lung cancer |
| Resveratrol | Lung Cancer | 24 | PM | 35892684 | 📋 | Resveratrol and Its Analogue 4,4'-Dihydroxy-trans-stilbene Inhibit Lewis Lung Carcinoma Growth In Vivo through Apoptosis, Autophagy and Modulation of the Tumour Microenvironment in a Murine Model |
| Resveratrol | Lung Cancer | 23 | PM | 35745143 | 📋 | Resveratrol Induces Autophagy and Apoptosis in Non-Small-Cell Lung Cancer Cells by Activating the NGFR-AMPK-mTOR Pathway |
| Resveratrol | Lung Cancer | 22 | PM | 35680166 | 📋 | RESVERATROL BINDS NUCLEAR RECEPTOR 4A1 (NR4A1) AND ACTS AS AN NR4A1 ANTAGONIST IN LUNG CANCER CELLS |
| Resveratrol | Lung Cancer | 21 | PM | 34633989 | 📋 | Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis |
| Resveratrol | Lung Cancer | 20 | PM | 34139546 | 📋 | Resveratrol inhibits MUC5AC expression by regulating SPDEF in lung cancer cells |
| Resveratrol | Lung Cancer | 19 | PM | 34129726 | 📋 | Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway |
| Resveratrol | Lung Cancer | 18 | PM | 33850559 | 📋 | Resveratrol sensitizes A549 cells to irradiation damage via suppression of store-operated calcium entry with Orai1 and STIM1 downregulation |
| Resveratrol | Lung Cancer | 17 | PM | 33652978 | 📋 | Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191 |
| Resveratrol | Lung Cancer | 16 | PM | 33539914 | 📋 | LC3B/p62-mediated mitophagy protects A549 cells from resveratrol-induced apoptosis |
| Resveratrol | Lung Cancer | 15 | PM | 33294270 | 📋 | Resveratrol-mediated ADAM9 degradation decreases cancer progression and provides synergistic effects in combination with chemotherapy |
| Resveratrol | Lung Cancer | 14 | PM | 32945383 | 📋 | Resveratrol modulates the apoptosis and autophagic death of human lung adenocarcinoma A549 cells via a p53‑dependent pathway: Integrated bioinformatics analysis and experimental validation |
| Resveratrol | Lung Cancer | 13 | PM | 32901891 | 📋 | Resveratrol inhibits viability and induces apoptosis in the small‑cell lung cancer H446 cell line via the PI3K/Akt/c‑Myc pathway |
| Resveratrol | Lung Cancer | 12 | PM | 32801741 | 📋 | Resveratrol Suppresses Tumor Progression via Inhibiting STAT3/HIF-1α/VEGF Pathway in an Orthotopic Rat Model of Non-Small-Cell Lung Cancer (NSCLC) |
| Resveratrol | Lung Cancer | 11 | PM | 32377734 | 📋 | Effect of SIRT1 Activators and Inhibitors on CD44+/CD133+‑enriched Non‑small Cell Lung Cancer Cells |
| Resveratrol | Lung Cancer | 10 | PM | 32326402 | 📋 | Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine Against Lung Cancer |
| Resveratrol | Lung Cancer | 9 | PM | 30031063 | 📋 | Resveratrol Sensitizes Lung Cancer Cell to TRAIL by p53 Independent and Suppression of Akt/NF-κB Signaling |
| Resveratrol | Lung Cancer | 8 | PM | 29872310 | 📋 | Resveratrol Inhibits the Proliferation of A549 Cells by Inhibiting the Expression of COX-2 |
| Resveratrol | Lung Cancer | 7 | PM | 27352348 | 📋 | Effect and Mechanism of Resveratrol on the Apoptosis of Lung Adenocarcinoma Cell Line A549 |
| Resveratrol | Lung Cancer | 5 | PM | 26314326 | 📋 | Resveratrol Enhanced Anticancer Effects of Cisplatin on Non-Small Cell Lung Cancer Cell Lines by Inducing Mitochondrial Dysfunction and Cell Apoptosis |
| Resveratrol | Lung Cancer | 3 | PM | 26124921 | 📋 | CArG-driven GADD45α Activated by Resveratrol Inhibits Lung Cancer Cells |
| Resveratrol | Lung Cancer | 6 | PM | 20461740 | 📋 | Resveratrol Inhibits Human Lung Adenocarcinoma Cell Metastasis by Suppressing Heme Oxygenase 1-mediated Nuclear factor-kappaB Pathway and Subsequently Downregulating Expression of Matrix Metalloproteinases |
| Resveratrol | Lung Cancer | 1 | PM | 20048747 | 📋 | 4'-Chloro-3,5-dihydroxystilbene, a Resveratrol Derivative, Induces Lung Cancer Cell Death |
| Resveratrol | Lung Cancer | 2 | PM | 20041413 | 📋 | Modulatory Effects of Curcumin and Resveratrol on Lung Carcinogenesis in Mice |
| Resveratrol | Lung Cancer | 4 | PM | 14666716 | 📋 | Combined Effects of Resveratrol and Paclitaxel on Lung Cancer Cells |
| Resveratrol | Lung Disease | 1 | PM | 32963508 | 📋 | Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases |
| Resveratrol | Lung Inflammation | 2 | PM | 34968999 | 📋 | Resveratrol attenuates inflammation and apoptosis through alleviating endoplasmic reticulum stress via Akt/mTOR pathway in fungus-induced allergic airways inflammation |
| Resveratrol | Lung Inflammation | 1 | PM | 31295660 | 📋 | Resveratrol Alleviates Chronic "Real-World" Ambient Particulate Matter-Induced Lung Inflammation and Fibrosis by Inhibiting NLRP3 Inflammasome Activation in Mice |
| Resveratrol | Lung Injury | 3 | PM | 38762209 | 📋 | Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection |
| Resveratrol | Lung Injury | 2 | PM | 35240708 | 📋 | Resveratrol attenuates hyperoxia lung injury in neonatal rats by activating SIRT1/PGC-1α signaling pathway |
| Resveratrol | Lung Injury | 1 | PM | 35001578 | 📋 | Resveratrol: A Potential Protector Against Benzo[a]pyrene- Induced Lung Toxicity |
| Resveratrol | Lung Injury | 4 | PM | 26334388 | 📋 | Protective Effect of Polyphenols in an Inflammatory Process Associated With Experimental Pulmonary Fibrosis in Mice |
| Resveratrol | Nasopharyngeal Cancer | 1 | PM | 20717957 | 📋 | Resveratrol Induces Apoptosis of Human Nasopharyngeal Carcinoma Cells via Activation of Multiple Apoptotic Pathways |
| Resveratrol | Oral Cancer | 18 | PM | 38575921 | 📋 | A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications |
| Resveratrol | Oral Cancer | 16 | PM | 36500345 | 📋 | Resveratrol Inhibits Proliferation and Induces Autophagy by Blocking SREBP1 Expression in Oral Cancer Cells |
| Resveratrol | Oral Cancer | 15 | PM | 36185249 | 📋 | A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004) |
| Resveratrol | Oral Cancer | 14 | PM | 36005140 | 📋 | Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer |
| Resveratrol | Oral Cancer | 13 | PM | 34577602 | 📋 | Polydatin, a Glycoside of Resveratrol, Induces Apoptosis and Inhibits Metastasis Oral Squamous Cell Carcinoma Cells In Vitro |
| Resveratrol | Oral Cancer | 12 | PM | 34273003 | 📋 | Resveratrol effects in oral cancer cells: a comprehensive review |
| Resveratrol | Oral Cancer | 11 | PM | 34176441 | 📋 | Resveratrol suppresses malignant progression of oral squamous cell carcinoma cells by inducing the ZNF750/RAC1 signaling pathway |
| Resveratrol | Oral Cancer | 10 | PM | 34085601 | 📋 | Resveratrol acts via melanoma-associated antigen A12 (MAGEA12)/protein kinase B (Akt) signaling to inhibit the proliferation of oral squamous cell carcinoma cells |
| Resveratrol | Oral Cancer | 9 | PM | 34008860 | 📋 | Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9 |
| Resveratrol | Oral Cancer | 8 | PM | 32728068 | 📋 | Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol |
| Resveratrol | Oral Cancer | 7 | PM | 32621571 | 📋 | Resveratrol Inhibits Oral Squamous Cell Carcinoma Cells Proliferation While Promoting Apoptosis Through Inhibition of CBX7 Protein |
| Resveratrol | Oral Cancer | 6 | PM | 32423320 | 📋 | Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells |
| Resveratrol | Oral Cancer | 2 | PM | 29148840 | 📋 | Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells |
| Resveratrol | Oral Cancer | 1 | PM | 28197628 | 📋 | Resveratrol-induced Autophagy and Apoptosis in Cisplatin-Resistant Human Oral Cancer CAR Cells: A Key Role of AMPK and Akt/mTOR Signaling |
| Resveratrol | Oral Cancer | 3 | PM | 26409447 | 📋 | Resveratrol Inhibits Oral Squamous Cell Carcinoma Through Induction of Apoptosis and G2/M Phase Cell Cycle Arrest |
| Resveratrol | Oral Cancer | 17 | PM | 24243690 | 📋 | Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses |
| Resveratrol | Oral Cancer | 5 | PM | 19484992 | 📋 | [Reversal Effect of Resveratrol on Chemotherapy Resistance in KBv200 Cell Line and Underlying Mechanisms] |
| Resveratrol | Oral Cancer | 4 | PM | 10211549 | 📋 | Modulating Effect of Resveratrol and Quercetin on Oral Cancer Cell Growth and Proliferation |
| Resveratrol | Oral Mucositis | 1 | PM | 34857985 | 📋 | Protective effects of resveratrol against 5-fluorouracil-induced oxidative stress and inflammatory responses in human keratinocytes |
| Resveratrol | Oral Submucous Fibrosis | 1 | PM | 38618058 | 📋 | Resveratrol inhibits arecoline-induced fibrotic properties of buccal mucosal fibroblasts via miR-200a activation |
| Resveratrol | Pulmonary Embolism | 1 | PM | 35932505 | 📋 | Resveratrol attenuates chronic pulmonary embolism-related endothelial cell injury by modulating oxidative stress, inflammation, and autophagy |
| Resveratrol | Pulmonary Fibrosis | 12 | PM | 37796708 | 📋 | Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis |
| Resveratrol | Pulmonary Fibrosis | 11 | PM | 37544448 | 📋 | Resveratrol mitigates miR-212-3p mediated progression of diesel exhaust-induced pulmonary fibrosis by regulating SIRT1/FoxO3 |
| Resveratrol | Pulmonary Fibrosis | 10 | PM | 36891982 | 📋 | Effects of Resveratrol on Pulmonary Fibrosis via TGF-β/Smad/ERK Signaling Pathway |
| Resveratrol | Pulmonary Fibrosis | 9 | PM | 34202229 | 📋 | SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment |
| Resveratrol | Pulmonary Fibrosis | 8 | PM | 33495418 | 📋 | Resveratrol alleviates bleomycin-induced pulmonary fibrosis via suppressing HIF-1α and NF-κB expression |
| Resveratrol | Pulmonary Fibrosis | 7 | PM | 32963508 | 📋 | Resveratrol extracted from Chinese herbal medicines: A novel therapeutic strategy for lung diseases |
| Resveratrol | Pulmonary Fibrosis | 6 | PM | 32952652 | 📋 | Polydatin prevents bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/Smad/ERK signaling pathway |
| Resveratrol | Pulmonary Fibrosis | 1 | PM | 31295660 | 📋 | Resveratrol Alleviates Chronic "Real-World" Ambient Particulate Matter-Induced Lung Inflammation and Fibrosis by Inhibiting NLRP3 Inflammasome Activation in Mice |
| Resveratrol | Pulmonary Fibrosis | 5 | PM | 30892165 | 📋 | Mitigation of Radiation-Induced Pneumonitis and Lung Fibrosis Using Alpha-Lipoic Acid and Resveratrol |
| Resveratrol | Pulmonary Fibrosis | 3 | PM | 29843043 | 📋 | Resveratrol Inhibits Pulmonary Fibrosis by Regulating miR-21 Through MAPK/AP-1 Pathways |
| Resveratrol | Pulmonary Fibrosis | 2 | PM | 26334388 | 📋 | Protective Effect of Polyphenols in an Inflammatory Process Associated With Experimental Pulmonary Fibrosis in Mice |
| Resveratrol | Pulmonary Fibrosis | 4 | PM | 21269063 | 📋 | Resveratrol Inhibits Transforming Growth Factor-β-Induced Proliferation and Differentiation of Ex Vivo Human Lung Fibroblasts Into Myofibroblasts Through ERK/Akt Inhibition and PTEN Restoration |
| Resveratrol | Pulmonary Hypertension | 7 | PM | 35932505 | 📋 | Resveratrol attenuates chronic pulmonary embolism-related endothelial cell injury by modulating oxidative stress, inflammation, and autophagy |
| Resveratrol | Pulmonary Hypertension | 6 | PM | 34239697 | 📋 | Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension |
| Resveratrol | Pulmonary Hypertension | 5 | PM | 33157235 | 📋 | Resveratrol: Mechanistic and Therapeutic Perspectives in Pulmonary Arterial Hypertension |
| Resveratrol | Pulmonary Hypertension | 4 | PM | 32798507 | 📋 | Systematic analysis of molecular mechanism of resveratrol for treating pulmonary hypertension based on network pharmacology technology |
| Resveratrol | Pulmonary Hypertension | 3 | PM | 28494457 | 📋 | Resveratrol Protects Against Pulmonary Arterial Hypertension in Rats via Activation of Silent Information Regulator 1 |
| Resveratrol | Pulmonary Hypertension | 1 | PM | 26273643 | 📋 | Regulation of Cell Cycle Regulators by SIRT1 Contributes to Resveratrol-Mediated Prevention of Pulmonary Arterial Hypertension |
| Resveratrol | Pulmonary Hypertension | 2 | PM | 19597040 | 📋 | Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats |
| Resveratrol | Respiratory Tract Infection | 1 | PM | 22391746 | 📋 | Resveratrol Inhibits Respiratory Syncytial Virus-Induced IL-6 Production, Decreases Viral Replication, and Downregulates TRIF Expression in Airway Epithelial Cells |
| Resveratrol | Respiratory Tract Infection | 2 | PM | 21937650 | 📋 | Resveratrol-mediated Gamma Interferon Reduction Prevents Airway Inflammation and Airway Hyperresponsiveness in Respiratory Syncytial Virus-Infected Immunocompromised Mice |
| Resveratrol | Septic Acute Lung Injury | 1 | PM | 34808102 | 📋 | Resveratrol alleviates acute lung injury through regulating PLSCR-3-mediated mitochondrial dysfunction and mitophagy in a cecal ligation and puncture model |
| Resveratrol | Sleep Apnea | 1 | PM | 33389500 | 📋 | Downregulated hypoxia-inducible factor 1α improves myoblast differentiation under hypoxic condition in mouse genioglossus |
| Resveratrol | Sore Throat | 2 | PM | 30505196 | 📋 | Resveratrol treatment inhibits acute pharyngitis in the mice model through inhibition of PGE2/COX-2 expression |
| Resveratrol | Sore Throat | 1 | PM | 29115472 | 📋 | Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF‑κB in animal models of acute pharyngitis |
